First orders for listed medical device brand
A medical device manufacturer has received its first commercial orders for its surgical endoscopy device.
The first purchase orders come from two US hospitals and follow on from the successful roll out of the company’s Clinical Education Programme in the US which has now trained seven practitioners across six hospitals.
According to the company, the orders represent a key milestone, with initial sales in-line with expectations on pricing and volume
The product has been used by a number of gastrointestinal (GI) endoscopists in the UK, South Africa, Mainland Europe and the US.
Craig Gulliford, chief executive of Creo, said: “It’s important to recognise this important milestone for the company. Having invested heavily in the development and regulatory clearance with the first product, followed by establishing a class leading professional education programme, this milestone marks the point where we can start to commercially build on the potential created with these foundations.
“Initial revenues from the first device this year is once again in-line with expectations and combined with the clearance and launch of a suite of further GI devices in the coming year, we are on-track for scaling up the commercial launch of a suite of game changing GI products.
“This is an exciting time for the team here at Creo, where the hard work continues to pay-off as we reel in significant corporate milestones but, more importantly, with the continued results for our patients. We are all really focussed on extending this impact with more physicians trained and with more products launched over the coming months.”